Dihydroergotamine Mesylate and Insulin Degludec (U-100) Vials
Determining the interaction of Dihydroergotamine Mesylate and Insulin Degludec (U-100) Vials and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection), Dihydroergotamine
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dihydroergotamine Mesylate-Insulin Degludec (U-200) Prefilled Pens
- Dihydroergotamine Mesylate-Insulin degludec and liraglutide
- Dihydroergotamine Mesylate-Insulin degludec and liraglutide Subcutaneous
- Dihydroergotamine Mesylate-Insulin degludec Subcutaneous
- Dihydroergotamine Mesylate-Insulin detemir
- Dihydroergotamine Mesylate-Insulin Detemir (Cartridges and Prefilled Syringes)
- Insulin Degludec (U-100) Vials-Dihydroergotamine nasal
- Insulin Degludec (U-100) Vials-Dihydroergotamine Nasal Spray
- Insulin Degludec (U-100) Vials-Dilacor XR
- Insulin Degludec (U-100) Vials-Dilantin
- Insulin Degludec (U-100) Vials-Dilantin Infatabs
- Insulin Degludec (U-100) Vials-Dilantin injection